Results 271 to 280 of about 36,199 (325)

How Effective Are Machine Learning and Doubly Robust Estimators in Incorporating High-Dimensional Proxies to Reduce Residual Confounding? [PDF]

Pharmacoepidemiol Drug Saf
Karim ME, Lei Y.
europepmc   +1 more source

A Brief Report on Proposed Areas of International Harmonization of Real-World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators. [PDF]

Pharmacoepidemiol Drug Saf
Nafie M, Parker VJ, McClellan M, Hendricks-Sturrup RM.   +3 more
europepmc   +1 more source

Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies. [PDF]

Front Pharmacol
Khan Z, Karatas Y, Akici A, Martins MAP, Ahmad N.   +4 more
europepmc   +1 more source

The hazard of using the Poisson model to cope with immortal time bias in the case of time-varying hazard. [PDF]

BMC Med Res Methodol
Rea F, Morabito G, Corrao G, Cantarutti A.   +3 more
europepmc   +1 more source

Therapeutic Benefit of Top-Selling Oncology Drugs in Medicare.

JAMA Netw Open
Wang S, Egilman AC, Hahn G, Kesselheim AS.   +3 more
europepmc   +1 more source

Using Pharmacoepidemiology to Examine the Interplay of Sulfonylureas and Infection Risk in Patients With Diabetes Mellitus. [PDF]

CPT Pharmacometrics Syst Pharmacol
Wu YY, Lin IF, Chen KH, Wang HH, Huang CK.   +4 more
europepmc   +1 more source

Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example. [PDF]

Am J Epidemiol
Bots SH, Belitser S, Groenwold RHH, Durán CE, Riera-Arnau J, Schultze A, Messina D, Segundo E, Douglas I, Carreras JJ, Garcia-Poza P, Gini R, Huerta C, Martín-Pérez M, Martin I, Paoletti O, Bissacco CA, Correcher-Martínez E, Souverein P, Urchueguía-Fornes A, Villalobos F, Sturkenboom MCJM, Klungel OH.   +22 more
europepmc   +1 more source

Use, Spending, and Prices of Adalimumab Following Biosimilar Competition.

JAMA Health Forum
Rome BN, Bhaskar A, Kesselheim AS.
europepmc   +1 more source

Anticholinergic drugs and dementia risk: Using stem cell-based studies to complement pharmacoepidemiology. [PDF]

Alzheimers Dement (N Y)
Schwarze-Taufiq TA, Pranoto IKA, Hui K, Kinoshita C, Yu O, Crane PK, Gray SL, Young JE.   +7 more
europepmc   +1 more source

Comment on: Increased Theophylline Plasma Concentrations in a Patient With COVID-19. [PDF]

Ann Pharmacother
Krohmer E, Haefeli WE.
europepmc   +1 more source